wada semaglutide GLP-1 weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be banned in sports for potentially being performance-enhancing drugs. https://fox5sandiego.com/news/critics-concerned-glp-1-drugs-may-give semaglutide wada 📢 WADA Prohibited

What Does the Clinical Evidence Actually Show

Alcohol: Caution is advised when consuming alcohol with Janumet, as it can potentiate the risk of lactic acidosis

This wide range suggests that modifiable factorsincluding protein intake and exercisesignificantly influence outcomes

Critical Price Increases (December 2025 - March 2026): Ingredient Price Increase Primary Use Thiocolchicide 106% Muscle relaxant Glycerin 64% Solvent, excipient Nimesulide 53% Pain relief Deflazacort 50% Steroid Clobetasol Propionate 47% Skin treatment Amoxicillin Trihydrate 45% Antibiotic Paracetamol 26% Fever, pain Diclofenac Sodium 25-30% Anti-inflammatory Ciprofloxacin 20-30% Antibiotic Solvents (IPA, Acetone) 20-30% Manufacturing Multiple Factors Driving Crisis: Rupee depreciation against US dollar Petroleum-linked solvent costs (oil at $115/barrel) Container shortages and vessel delays from China Opportunistic pricing by some suppliers Industry Response: The Federation of Pharma Entrepreneurs has formally requested NPPA intervention, seeking permission for price hikes under DPCO 2013 Para 19

Pre-existing gastrointestinal disease, impaired kidney function, dehydration, and advanced age can prolong or worsen side effects

National Academy of Sports Medicine